[Event Report] Special International Forum: The Importance of Vaccines and Japan’s Role in Global Health (October 22, 2021)
date : 11/1/2021
Tags: Vaccinations
Health and Global Policy Institute (HGPI) convened an online Special International Forum: “The Importance of Vaccines and Japan’s Role in Global Health.”
The importance of vaccines in the context of global health has started to take up more space in the vaccine policy debate than ever before. As the impact of COVID-19 is felt in developing, as well as developed countries, a global, collaborative framework (ACT-A: Access to COVID-19 Tools Accelerator) to accelerate access to tools related to COVID-19 has been launched. Through the COVAX Facility, a multilateral framework for the procurement and distribution of safe and approved vaccines has been established. Furthermore, international contributions are being made through bilateral vaccine donations. Japan has engaged in various international cooperation initiatives through its Strategy on Global Health Diplomacy, approved by the Cabinet in 2013, and the Basic Design for Peace and Health (Global Health Cooperation), created in 2015.
At the same time, the international supply of COVID-19 vaccines has been unevenly distributed, with middle- and high-income countries receiving more vaccines and low-income countries receiving far fewer. Recently, there have been calls around the world for vaccines to be classified as “Global Public Goods” and it is essential that we expand the conversation to promote public and stakeholder interest and understanding of international contributions and diplomatic issues related to COVID-19.
The Special International Forum focused on Japan’s global provision of COVID-19 vaccines, the COVAX Facility’s current status and prospects, and Japan’s future role in health diplomacy. Experts from industry, government, academia, and the private sector in Japan and abroad engaged in discussions on the significance of medicines, including vaccines, to global health and the role expected of Japan moving forward.
■Date: Friday, October 22, 2021, 15:30-18:00 JST
■Format: Zoom Webinar
■Participation Fee: Free
■Language: English and Japanese (simultaneous interpretation available)
■Host: Health and Global Policy Institute
■Co-host: The British Embassy Japan
■Program: (Titles omitted)
15:30-15:35 Opening Address (1)
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
15:35-15:40 Opening Address (2)
Julia Longbottom (British Ambassador to Japan)
15:40-15:45 Event Overview
Ryoji Noritake (CEO & Board Member, Health and Global Policy Institute)
15:45-16:00 Keynote Speech (1) Lessons Learned from UK’s Vaccine Rollout and Global Health Strategy
Saul Walker (Deputy Head of COVID-19 Vaccines, Therapeutics and Diagnostics Strategy, Foreign Commonwealth and Development Office(FCDO), UK)
16:00-16:15 Keynote Speech (2) Japan’s International Collaboration Efforts in the COVID-19 Era
Satoshi Ezoe (Director, Global Health Policy Division, Ministry of Foreign Affairs, Japan)
Panelists:
Mihoko Kashiwakura (Head of East Asia Relations, Bill & Melinda Gates Foundation)
Keizo Takemi (Member of the House of Councilors; WHO Goodwill Ambassador for UHC)
Atsushi Sunami (President, The Sasakawa Peace Foundation)
Kayo Takuma (Professor, Tokyo Metropolitan University)
Suwit Wibulpolprasert (Senior Advisor, Thai Ministry of Health)
Moderator:
Joji Sugawara (Manager, Health and Global Policy Institute)
17:50-18:00 Closing Remarks
Noriko Furuya (Member of the House of Representatives; Acting Chairperson, Association for the Promotion of Improved Public Health, Parliamentary Group for Vaccines and Prevention)
*Please find out the brochure at the bottom of this website for more information.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)